Home
ANIP
ANIP News

Latest ANI Pharmaceuticals Inc. (ANIP) News on May 16, 2025

Pharmaceuticals Stocks Q1 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

StockStory

2 days ago

Pharmaceuticals Stocks Q1 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

Argus Research

2 days ago

ANIP: Lowering target price to $65.00

3 Small-Cap Stocks Walking a Fine Line

StockStory

3 days ago

3 Small-Cap Stocks Walking a Fine Line

ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ

GlobeNewswire

3 days ago

ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ

ANI (ANIP) is an Incredible Growth Stock: 3 Reasons Why

Zacks

4 days ago

ANI (ANIP) is an Incredible Growth Stock: 3 Reasons Why

ANI Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.

6 days ago

ANI Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations

GuruFocus.com

6 days ago

ANI Pharmaceuticals Inc (ANIP) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ...

Cortrophin Demand Is Soaring For ANI Pharma, CEO Says Well-Positioned To Mitigate Potential Tariff Impact

Benzinga

7 days ago

Cortrophin Demand Is Soaring For ANI Pharma, CEO Says Well-Positioned To Mitigate Potential Tariff Impact

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?

Zacks

7 days ago

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?

Compared to Estimates, ANI (ANIP) Q1 Earnings: A Look at Key Metrics

Zacks

7 days ago

Compared to Estimates, ANI (ANIP) Q1 Earnings: A Look at Key Metrics

MT Newswires

7 days ago

Sector Update: Health Care Stocks Flat to Higher Premarket Friday

MT Newswires

7 days ago

Top Premarket Gainers

ANI Pharmaceuticals (ANIP) Tops Q1 Earnings and Revenue Estimates

Zacks

7 days ago

ANI Pharmaceuticals (ANIP) Tops Q1 Earnings and Revenue Estimates

Associated Press Finance

7 days ago

ANI: Q1 Earnings Snapshot

MT Newswires

7 days ago

ANI Pharmaceuticals Q1 Adjusted Earnings, Revenue Rise; 2025 Outlook Raised

ANI Pharmaceuticals (NASDAQ:ANIP) Reports Strong Q1, Full-Year Outlook Slightly Exceeds Expectations

StockStory

7 days ago

ANI Pharmaceuticals (NASDAQ:ANIP) Reports Strong Q1, Full-Year Outlook Slightly Exceeds Expectations

ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance

GlobeNewswire

7 days ago

ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance

Pacira (PCRX) Q1 Earnings Surpass Estimates

Zacks

7 days ago

Pacira (PCRX) Q1 Earnings Surpass Estimates

ANI Pharmaceuticals Inc (ANIP) Q1 2025: Everything You Need To Know Ahead Of Earnings

GuruFocus.com

8 days ago

ANI Pharmaceuticals Inc (ANIP) Q1 2025: Everything You Need To Know Ahead Of Earnings

Earnings To Watch: ANI Pharmaceuticals (ANIP) Reports Q1 Results Tomorrow

StockStory

8 days ago

Earnings To Watch: ANI Pharmaceuticals (ANIP) Reports Q1 Results Tomorrow

Argus Research

9 days ago

ANIP: What does Argus have to say about ANIP?

ANI Pharmaceuticals to Report Q1 Earnings: Is a Beat in the Cards?

Zacks

11 days ago

ANI Pharmaceuticals to Report Q1 Earnings: Is a Beat in the Cards?

ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue?

Zacks

11 days ago

ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue?

ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis (EAU) Mouse Model

GlobeNewswire

11 days ago

ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis (EAU) Mouse Model

ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks

14 days ago

ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Generic Pharmaceuticals Stocks Q4 Teardown: Viatris (NASDAQ:VTRS) Vs The Rest

StockStory

18 days ago

Generic Pharmaceuticals Stocks Q4 Teardown: Viatris (NASDAQ:VTRS) Vs The Rest

1 of Wall Street’s Favorite Stock to Target This Week and 2 to Keep Off Your Radar

StockStory

19 days ago

1 of Wall Street’s Favorite Stock to Target This Week and 2 to Keep Off Your Radar

3 Reasons Growth Investors Will Love ANI (ANIP)

Zacks

21 days ago

3 Reasons Growth Investors Will Love ANI (ANIP)

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Zacks

21 days ago

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season?

Zacks

21 days ago

Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season?

Zacks.com featured highlights include Heritage Insurance, Marex, Kingstone, ANI Pharmaceuticals and HCI

Zacks

22 days ago

Zacks.com featured highlights include Heritage Insurance, Marex, Kingstone, ANI Pharmaceuticals and HCI

Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year?

Zacks

23 days ago

Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year?

Zacks.com featured highlights include ANI Pharmaceuticals, Heritage Insurance, Avista and Exelon

Zacks

23 days ago

Zacks.com featured highlights include ANI Pharmaceuticals, Heritage Insurance, Avista and Exelon

5 Stocks With Recent Price Strength Amid Tariff-Led Volatility

Zacks

23 days ago

5 Stocks With Recent Price Strength Amid Tariff-Led Volatility

Argus Research

23 days ago

ANIP: Lowering target price to $72.00

4 Stocks Trading Near 52-Week High With Room to Rise Further

Zacks

24 days ago

4 Stocks Trading Near 52-Week High With Room to Rise Further

MT Newswires

25 days ago

Truist Lifts Price Target on ANI Pharmaceuticals to $65 From $62, Keeps Hold Rating

ANI Pharmaceuticals, Inc. (ANIP) Soars to 52-Week High, Time to Cash Out?

Zacks

a month ago

ANI Pharmaceuticals, Inc. (ANIP) Soars to 52-Week High, Time to Cash Out?

Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

StockStory

a month ago

Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

Argus Research

a month ago

ANIP: Raising target price to $73.00

ANI Pharmaceuticals (ANIP): Buy, Sell, or Hold Post Q4 Earnings?

StockStory

a month ago

ANI Pharmaceuticals (ANIP): Buy, Sell, or Hold Post Q4 Earnings?

IBD 50 Stock Flashes 'Golden Cross' But Massive Risk Looms

Investor's Business Daily

a month ago

IBD 50 Stock Flashes 'Golden Cross' But Massive Risk Looms

VALN Doses First Infant With Shigella Vaccine in Mid-Stage Study

Zacks

a month ago

VALN Doses First Infant With Shigella Vaccine in Mid-Stage Study

3 Reasons Why Growth Investors Shouldn't Overlook ANI (ANIP)

Zacks

a month ago

3 Reasons Why Growth Investors Shouldn't Overlook ANI (ANIP)

Will ANI (ANIP) Beat Estimates Again in Its Next Earnings Report?

Zacks

a month ago

Will ANI (ANIP) Beat Estimates Again in Its Next Earnings Report?

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks

a month ago

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET

GlobeNewswire

a month ago

ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET

Argus Research

a month ago

ANIP: Lowering target price to $66.00

Zacks.com featured highlights ANI Pharmaceuticals, Expand Energy, Avista Corp and Contango ORE

Zacks

a month ago

Zacks.com featured highlights ANI Pharmaceuticals, Expand Energy, Avista Corp and Contango ORE

Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?

Zacks

a month ago

Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?

Tariff Woes? Play Safe With 4 Low-Beta Stocks: ANIP, EXE, AVA & CTGO

Zacks

a month ago

Tariff Woes? Play Safe With 4 Low-Beta Stocks: ANIP, EXE, AVA & CTGO

Is the Options Market Predicting a Spike in ANI Pharmaceuticals (ANIP) Stock?

Zacks

a month ago

Is the Options Market Predicting a Spike in ANI Pharmaceuticals (ANIP) Stock?

3 Russell 2000 Stocks in the Doghouse

StockStory

a month ago

3 Russell 2000 Stocks in the Doghouse

Zacks.com featured highlights include HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree

Zacks

a month ago

Zacks.com featured highlights include HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree

Argus Research

a month ago

ANIP: Raising target price to $71.00

5 Relative Price Strength Stocks to Navigate Today's Market

Zacks

a month ago

5 Relative Price Strength Stocks to Navigate Today's Market

ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference

GlobeNewswire

2 months ago

ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference

Argus Research

2 months ago

ANIP: Raising target price to $70.00

5 Top-Ranked Mid-Cap Stocks to Buy for a Stellar Portfolio

Zacks

2 months ago

5 Top-Ranked Mid-Cap Stocks to Buy for a Stellar Portfolio

Is ANI (ANIP) a Solid Growth Stock? 3 Reasons to Think "Yes"

Zacks

2 months ago

Is ANI (ANIP) a Solid Growth Stock? 3 Reasons to Think "Yes"

Wall Street Analysts Think ANI (ANIP) Could Surge 26.83%: Read This Before Placing a Bet

Zacks

2 months ago

Wall Street Analysts Think ANI (ANIP) Could Surge 26.83%: Read This Before Placing a Bet

Should You Buy ANI Pharmaceuticals (ANIP) After Golden Cross?

Zacks

2 months ago

Should You Buy ANI Pharmaceuticals (ANIP) After Golden Cross?

Is Corcept Therapeutics (CORT) Stock Outpacing Its Medical Peers This Year?

Zacks

2 months ago

Is Corcept Therapeutics (CORT) Stock Outpacing Its Medical Peers This Year?

MT Newswires

2 months ago

Ani Pharmaceuticals Launches Nitazoxanide Tablets for Treating Diarrhea

ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets

GlobeNewswire

2 months ago

ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets

Teva Pharmaceutical Stock Scores RS Rating Upgrade

Investor's Business Daily

2 months ago

Teva Pharmaceutical Stock Scores RS Rating Upgrade

MT Newswires

2 months ago

ANI Pharmaceuticals Completes Buyout of Royalty Obligation for Iluvien, Yutiq

ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ®

GlobeNewswire

2 months ago

ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ®

Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment

StockStory

2 months ago

Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment

MT Newswires

2 months ago

ANI Pharmaceuticals Says FDA Approves Expanded Label for Iluvien

MT Newswires

2 months ago

Jefferies Initiates Coverage on ANI Pharmaceuticals With Buy Rating, $80 Price Target

ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label

GlobeNewswire

2 months ago

ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label

Relative Price Strength: A Smart Strategy Amid Market Turmoil

Zacks

2 months ago

Relative Price Strength: A Smart Strategy Amid Market Turmoil

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

StockStory

2 months ago

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

BIIB Starts Felzartamab Phase III Study in AMR in Kidney Transplant

Zacks

2 months ago

BIIB Starts Felzartamab Phase III Study in AMR in Kidney Transplant

Zacks.com featured highlights include ANI Pharmaceuticals, Dana, Pitney Bowes, Priority Technology and Kingstone

Zacks

2 months ago

Zacks.com featured highlights include ANI Pharmaceuticals, Dana, Pitney Bowes, Priority Technology and Kingstone

1 Growth Stock to Target This Week and 2 to Avoid

StockStory

2 months ago

1 Growth Stock to Target This Week and 2 to Avoid

MT Newswires

2 months ago

JPMorgan Initiates ANI Pharmaceuticals at Overweight With $85 Price Target

MT Newswires

2 months ago

Ani Pharmaceuticals Insider Sold Shares Worth $323,049, According to a Recent SEC Filing

Wall Street Analysts Believe ANI (ANIP) Could Rally 32.4%: Here's is How to Trade

Zacks

2 months ago

Wall Street Analysts Believe ANI (ANIP) Could Rally 32.4%: Here's is How to Trade

ANI (ANIP) is an Incredible Growth Stock: 3 Reasons Why

Zacks

2 months ago

ANI (ANIP) is an Incredible Growth Stock: 3 Reasons Why

ANI (ANIP) Upgraded to Strong Buy: Here's What You Should Know

Zacks

2 months ago

ANI (ANIP) Upgraded to Strong Buy: Here's What You Should Know

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

Zacks

2 months ago

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?

Zacks

2 months ago

Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

StockStory

2 months ago

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

Argus Research

2 months ago

ANIP: Raising target price to $47.00

ANI Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

2 months ago

ANI Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

MT Newswires

2 months ago

ANI Pharmaceuticals Gets FDA Approval for Cortrophin Gel in Prefilled Syringe Format as MS Therapy

ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe

GlobeNewswire

2 months ago

ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe

Thomson Reuters StreetEvents

3 months ago

Q4 2024 ANI Pharmaceuticals Inc Earnings Call

GuruFocus.com

3 months ago

ANI Pharmaceuticals Inc (ANIP) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...

Why Is ANI Pharmaceuticals (ANIP) Stock Soaring Today

StockStory

3 months ago

Why Is ANI Pharmaceuticals (ANIP) Stock Soaring Today

MT Newswires

3 months ago

Sector Update: Health Care Stocks Softer Friday Afternoon

ANI (ANIP) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

3 months ago

ANI (ANIP) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

MT Newswires

3 months ago

Sector Update: Health Care Stocks Steady Pre-Bell Friday

MT Newswires

3 months ago

Sector Update: Health Care

Associated Press Finance

3 months ago

ANI: Q4 Earnings Snapshot

MT Newswires

3 months ago

ANI Pharmaceuticals' Q4 Adjusted Earnings, Revenue Rise; Provides 2025 Outlook

ANI Pharmaceuticals (NASDAQ:ANIP) Delivers Impressive Q4, Stock Soars

StockStory

3 months ago

ANI Pharmaceuticals (NASDAQ:ANIP) Delivers Impressive Q4, Stock Soars

ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance

GlobeNewswire

3 months ago

ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance

Share on Social Networks: